Flagship Pioneering’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,293,849	Closed	-$2.78M	–	6
2024 Q3	$2.78M	Hold	1,293,849	–	–	0.47%	6
2024 Q2	$6.68M	Hold	1,293,849	–	–	0.79%	6
2024 Q1	$6.92M	Buy	1,293,849 +1	+0%	+$5	0.45%	7
2023 Q4	$10.1M	Buy	1,293,848 +300,000	+30%	+$2.34M	0.76%	7
2023 Q3	$3.93M	Hold	993,848	–	–	0.29%	9
2023 Q2	$3.13M	Hold	993,848	–	–	0.14%	10
2023 Q1	$2.65M	Hold	993,848	–	–	0.1%	10
2022 Q4	$3.57M	Hold	993,848	–	–	0.11%	11
2022 Q3	$6.4M	Buy	993,848 +699,999	+238%	+$4.51M	0.27%	10
2022 Q2	$2.82M	Hold	293,849	–	–	0.11%	12
2022 Q1	$3.5M	Hold	293,849	–	–	0.08%	13
2021 Q4	$9.58M	Hold	293,849	–	–	0.15%	13
2021 Q3	$13.1M	Hold	293,849	–	–	0.14%	13
2021 Q2	$16M	Hold	293,849	–	–	0.2%	12
2021 Q1	$22M	Hold	293,849	–	–	0.35%	12
2020 Q4	$31.9M	Hold	293,849	–	–	0.58%	11
2020 Q3	$26M	Hold	293,849	–	–	0.72%	8
2020 Q2	$31.3M	Hold	293,849	–	–	0.91%	8
2020 Q1	$17.4M	Hold	293,849	–	–	0.82%	8
2019 Q4	$20.3M	Hold	293,849	–	–	1.14%	8
2019 Q3	$30.5M	Sell	293,849 -26,595	-8%	-$2.76M	1.67%	9
2019 Q2	$29.7M	Hold	320,444	–	–	1.28%	10
2019 Q1	$29.3M	Hold	320,444	–	–	1.11%	8
2018 Q4	$17.8M	Hold	320,444	–	–	0.87%	7
2018 Q3	$38.2M	Hold	320,444	–	–	2.52%	6
2018 Q2	$32.7M	Hold	320,444	–	–	6.27%	4
2018 Q1	$41.6M	Hold	320,444	–	–	12.06%	3
2017 Q4	$31.2M	Hold	320,444	–	–	7.91%	5
2017 Q3	$47.2M	Sell	320,444 -160,222	-33%	-$23.6M	15.78%	2
2017 Q2	$77.3M	Hold	480,666	–	–	27.27%	2
2017 Q1	$76.6M	Hold	480,666	–	–	20.35%	2
2016 Q4	$58.4M	Hold	480,666	–	–	19.02%	2
2016 Q3	$66.7M	Buy	+480,666	New	+$66.7M	18.22%	2